Hiroshi Maruta

5.3k total citations
144 papers, 4.3k citations indexed

About

Hiroshi Maruta is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Hiroshi Maruta has authored 144 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 34 papers in Cell Biology and 18 papers in Oncology. Recurrent topics in Hiroshi Maruta's work include Protein Kinase Regulation and GTPase Signaling (21 papers), Cellular Mechanics and Interactions (13 papers) and Glycosylation and Glycoproteins Research (9 papers). Hiroshi Maruta is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (21 papers), Cellular Mechanics and Interactions (13 papers) and Glycosylation and Glycoproteins Research (9 papers). Hiroshi Maruta collaborates with scholars based in Japan, Australia and United States. Hiroshi Maruta's co-authors include Edward D. Korn, Hong He, M S Nur-E-Kamal, Antony W. Burgess, Anjali Tikoo, Yumiko Hirokawa, G. Isenberg, Hisako Muramatsu, Tadaomi Takenawa and Mikael Varga and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Hiroshi Maruta

139 papers receiving 4.1k citations

Peers

Hiroshi Maruta

ONCOL

CCM

NEURO

Oriano Marin Italy

Shinobu Imajoh‐Ohmi Japan

Andreas Billich Austria

Vincent Duronio Canada

Enrique Calvo Spain

John H. Walker United Kingdom

Tsutomu Fujimura Japan

Alexey Kotlyarov Germany

David J. Livingston United States

Oriano Marin Italy

Hiroshi Maruta

4.4k ×1.8

863 ×0.5

680 ×1.2

ONCOL

160 ×0.5

CCM

156 ×0.6

NEURO

Citations per year, relative to Hiroshi Maruta Hiroshi Maruta (= 1×) peers Oriano Marin

Countries citing papers authored by Hiroshi Maruta

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Maruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Maruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Maruta more than expected).

Fields of papers citing papers by Hiroshi Maruta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Maruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Maruta. The network helps show where Hiroshi Maruta may publish in the future.

Co-authorship network of co-authors of Hiroshi Maruta

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Maruta. A scholar is included among the top collaborators of Hiroshi Maruta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Maruta. Hiroshi Maruta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nonaka, Takashi, et al.. (2024). Evaluation of intestinal wall closure using vessel-sealing technology versus conventional closure: an in vivo study. Surgery Today. 55(7). 865–873. 1 indexed citations

Maruta, Hiroshi & Hong He. (2020). PAK1-blockers: Potential Therapeutics against COVID-19. SHILAP Revista de lepidopterología. 6. 100039–100039. 87 indexed citations

Maruta, Hiroshi & Mok‐Ryeon Ahn. (2017). From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy. European Journal of Medicinal Chemistry. 142. 229–243. 22 indexed citations

Nguyen, Binh Cao Quan, Hideaki Takahashi, Yoshihiro Uto, et al.. (2016). 1,2,3-Triazolyl ester of Ketorolac: A “Click Chemistry”-based highly potent PAK1-blocking cancer-killer. European Journal of Medicinal Chemistry. 126. 270–276. 38 indexed citations

Messerli, Shanta M., Mok‐Ryeon Ahn, Kazuhiro Kunimasa, et al.. (2008). Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice. Phytotherapy Research. 23(3). 423–427. 82 indexed citations

Hirokawa, Yumiko, C. Oliver Hanemann, Armin Kurtz, et al.. (2005). Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biology & Therapy. 4(4). 385–387. 30 indexed citations

Hirokawa, Yumiko, et al.. (2005). Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance. Cancer Biology & Therapy. 4(9). 956–960. 66 indexed citations

Maruta, Hiroshi, et al.. (2004). Modeling and Detection of Stiction in Pneumatic Control Valve. Transactions of the Society of Instrument and Control Engineers. 40(8). 825–833. 11 indexed citations

He, Hong, Yumiko Hirokawa, Aviv Gazit, et al.. (2004). The Tyr-Kinase Inhibitor AG879, that Blocks the ETK-PAK1 Interaction, Suppresses the RAS-induced PAK1 Activation and Malignant Transformation. Cancer Biology & Therapy. 3(1). 96–101. 31 indexed citations

10.

Maruta, Hiroshi, Hong He, & Thao Nheu. (2003). Interfering with Ras Signaling Using Membrane-Permeable Peptides or Drugs. Humana Press eBooks. 189. 75–85. 14 indexed citations

11.

Maruta, Hiroshi. (2002). Tumor-suppressing viruses, genes, and drugs : innovative cancer therapy approaches. Academic Press eBooks. 3 indexed citations

12.

Kano, Manabu, Shouhei Tanaka, Hiroshi Maruta, et al.. (2002). Statistical Process Monitoring with External Analysis and Independent Component Analysis. Transactions of the Society of Instrument and Control Engineers. 38(11). 958–965. 3 indexed citations

13.

Tikoo, Anjali, Lisa Connolly, Bill Bowers, et al.. (2000). Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.. PubMed. 6(3). 162–8. 20 indexed citations

14.

Tikoo, Anjali, Carrie S. Viars, Sara J. White, et al.. (2000). p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. Gene. 257(1). 23–31. 46 indexed citations

15.

Nur-E-Kamal, M S, M.M. Qureshi, Jabeen Kamal, W Montague, & Hiroshi Maruta. (1999). Construction of a Cell‐Permeable CDC42 Binding Fragment of ACK That Inhibits v‐Ha‐Ras Transformation. Annals of the New York Academy of Sciences. 886(1). 285–288. 5 indexed citations

16.

Hattori, Masakazu, Noriyuki Tsukamoto, M S Nur-E-Kamal, et al.. (1995). Molecular Cloning of a Novel Mitogen-Inducible Nuclear Protein with a Ran GTPase-Activating Domain That Affects Cell Cycle Progression. Molecular and Cellular Biology. 15(1). 552–560. 69 indexed citations

17.

Itoh, Naoki, et al.. (1994). Changes in the Endocrinological Milieu After Clomiphene Citrate Treatment for Oligozoospermia: The Clinical Significance of the Estradiol/Testosterone Ratio as a Prognostic Value. Journal of Andrology. 15(5). 449–455. 5 indexed citations

18.

Fabri, Louis, et al.. (1992). Characterization of bovine heparin-binding neurotrophic factor (HBNF): assignment of disulfide bonds.. PubMed. 28(1). 1–9. 11 indexed citations

19.

Nur-E-Kamal, M S & Hiroshi Maruta. (1992). The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.. Molecular Biology of the Cell. 3(12). 1437–1442. 14 indexed citations

20.

Tanaka, Noriaki, Takaoki Hirose, Yoshiaki Kumamoto, et al.. (1991). Antimicrobial activities and clinical studies on cefclidin in complicated urinary tract infections. Chemotherapy. 39(2). 206–213. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact